Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”

Documenti analoghi

• Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients
  di: Tokiyoshi Tanegashima, et al.
  Pubblicazione: (2024)
• Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
  di: Thomas Büttner, et al.
  Pubblicazione: (2024)
• A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer
  di: Pei‐Chen Ye, et al.
  Pubblicazione: (2024)
• PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
  di: Philip Sutera, et al.
  Pubblicazione: (2024)
• A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer
  di: Daniel Boiarsky, et al.
  Pubblicazione: (2024)